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Purpose: To describe the clinical findings of a patient with an early onset retinal dystrophy and a novel mutation in
OTX2, and to compare these findings with previously reported cases.
Methods: Using direct sequencing, we screened 142 patients, who had either Leber congenital amaurosis (LCA) or early
onset retinal dystrophy (EORD), for mutations in OTX2. All patients received a detailed ophthalmic examination including
electroretinography and retinal imaging.
Results: Only one mutation in OTX2 was identified. A novel heterozygous p.S138X stop mutation was identified in a
seven-year-old male who had an infantile onset retinal dystrophy. The mutation was not present in either parent or in 181
blood donor samples. There was a history of failure to thrive in infancy, poor feeding, and growth hormone deficiency.
Poor vision and nyctalopia was present from the first year. Funduscopy revealed a hyperpigmented peripapillary ring with
a fine granular pigmentation of the RPE throughout the fundus. The scotopic bright flash ERG a-wave was subnormal
and the waveform electronegative, in keeping with dysfunction both at the level of the photoreceptor and post-
phototransduction. Visual function has been stable to date.
Conclusions: Mutations in OTX2 have been reported in association with major developmental malformations of the eye,
with retinal dystrophies such as LCA, and with pituitary dysfunction and seizure activity in some cases. This case adds
further support for a role of OTX2 both in retinal development and pituitary function, and highlights a novel retinal
dystrophy phenotype seen in association with mutations in OTX2.
The orthodenticle protein homolog 2 (OTX2) is a
homeobox gene that plays a critical role in retinal
photoreceptor development. The gene, on chromosome
14q23.1, is organized into five exons, only three of which are
translated. It contains a highly conserved homeodomain.
OTX2 is expressed during development in the
neuroepithelium of most of the forebrain and midbrain,
including the eye domain [1]. Complete elimination of
OTX2 function in mice by gene targeting results in the absence
of the forebrain and embryonic lethality [2,3]. While Otx2 null
embryos display a severe cranial phenotype, lacking the
anterior neuroectoderm, and with abnormalities in body plan
[2,3], heterozygous deletion of Otx2 leads to a variable
phenotype that is dependent on genetic background. Otx2+/−
mice can be normal, have developmental eye anomalies
including anterior segment malformations, severe eye
abnormalities such as microphthalmia or anophthalmia, or
head abnormalities [2,4]. In early development Otx2, specifies
the anterior neuroectoderm during gastrulation [2] and is
expressed throughout the forebrain and midbrain in the
developing embryo [1]. Once eye development is specified,
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expression of Otx2 narrows. It is required for the development
of the presumptive retinal pigment epithelium (RPE) [5],
where it has a continuing maintenance role throughout
adulthood [6]. Analysis of Otx2−/− mice has shown that it is
essential for specification of the RPE; loss of OTX2 function
results in the outer layer of the optic cup developing into
ectopic neural retina [7]. However, OTX2 is also required for
the development and maintenance of the neural retina. Otx2
protein is found in bipolar and in ganglion cells [6,8,9], while
in the outer nuclear layer it regulates the expression of the
closely related Crx gene that controls the expression of a suite
of photoreceptor function genes, including opsins. Otx2 and
Crx can also bind to common DNA-binding sequences [10].
Ablation of OTX2 in retinal progenitor cells has been shown
to affect RPE development and leads to a significant decrease
in rod photoreceptors and bipolar cells, suggesting that OTX2
is also involved in retinal bipolar cell development [8]. It has
recently been demonstrated that OTX2 protein is transported
from the retina to the visual cortex in the developing rat, and
appears to modify postnatal synaptic plasticity [9].
OTX2 mutations in humans have been associated with a
range of ophthalmological phenotypes including
anophthalmia, microphthalmia, developmental anomalies of
the optic nerve and chiasm, and Leber congenital amaurosis
(LCA). As OTX2 plays a key role in retinal development, and
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a mutation in OTX2 has been reported in association with an
infantile onset retinal dystrophy [11], we screened a large
panel of patients with LCA and other forms of childhood onset
retinal dystrophy for mutations in this gene.
METHODS
A panel of DNA from 142 patients with LCA and severe
childhood onset retinal dystrophy were recruited at
Moorfields Eye Hospital and The Hospital for Children, Great
Ormond Street, London, as part of an ongoing molecular
genetic study of childhood retinal dystrophies. The research
has local research ethics committee approval and conformed
to the tenets of the Declaration of Helsinki. A full clinical
history was taken and examination performed in all subjects.
In older children and adults this included, where possible, best
corrected logMAR visual acuity and color vision (Hardy Rand
Rittler, Richmond Products, Albuquerque, NM); slit-lamp
biomicroscopy or indirect ophthalmoscopy; Goldmann visual
fields; autorefraction (Luneau L62–3D
autorefractokeratometer - LUNEAU Chartres, France), axial
length measurement, and auto-keratometry (IOL Master, Carl
Zeiss Meditec, Dublin, CA); optical coherence tomography
(Stratus OCT™ - software version 3; Carl Zeiss Meditec,
Inc.); fundus photography (TRC-50IX with IMAGEnet 2000
system software–TOPCON Corporation, Japan), and fundus
autofluorescence (Heidelberg Retinal Angiograph-II,
Heidelberg Engineering, Heidelberg, Germany). All patients
had electroretinography performed either at our institutions or
at the referring hospital. Most patients had tests performed at
diagnosis which, in the older patients, predated the ISCEV
standards. Patients seen more recently, or in whom we wished
to confirm the diagnosis, had electroretinography conducted
in accordance with current International Society for Clinical
Electrophysiology of Vision standards using gold foil or DTL
electrodes [12,13]. ERG testing in infants and young children
was performed using skin electrodes in accordance with
previously published protocols [14,15].
DNA was extracted from whole blood obtained from each
affected individual and immediate family members using the
Nucleon BACC-2 kit (GE Healthcare) performed as per
manufacturer’s instructions. DNA samples from all patients
were sent to Asper Ophthalmics (Tartu, Estonia) for analysis
using the LCA chip [16]. This is a microarray which contained
(at the time of the study) 344 disease associated SNPs and
several common variant polymorphisms in six LCA
associated genes and 2 early onset genes (GUCY2D, CRX,
RPE65, CRB1, RPGRIP1, AIPL1, LRAT, and MERTK).
Genorama genotyping software (Asper Ophthalmics Ltd) can
subsequently produce a bidirectional allele call at each SNP
being interrogated. The panel subsequently underwent direct
sequencing of PCR products [11] performed using an ABI
3130 36 cm capillary sequencer (Applied Biosystems, Inc.,
Foster City, CA). 181 control DNA samples isolated from
anonymous Aberdeen-based blood donors were screened for
DNA mismatches using the Idaho Technology Inc. Light
Scanner (Salt Lake City, UT). Fragments revealing a
nucleotide mismatch were fully sequenced to identify the
mutations.
RESULTS
A de novo heterozygous c.413C>G p.S138X stop mutation
was identified in a seven-year-old male (Figure 1; Pt 13424)
who was negative for all variants assayed by the LCA chip.
The mutation was not present in either parent. This mutation
was not detected in 181 controls. Known polymorphic single
nucleotide polymorphisms (SNPs), were observed at similar
frequencies in the disease cohort and the blood donor controls,
indicating that the ethnic background of the patient cohort and
the controls was comparable.
Figure 1. Direct sequencing. At the
position indicated by the black
arrowhead, the heterozygous C>G
change is revealed in the DNA sequence
trace for patient NH13424. Below this
the wild type trace for normal control
subject DIFIG is shown.
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The patient had a history of failure to thrive from birth
and multiple investigations of the possible cause including
investigations for Batten disease, Williams syndrome, and
Russell-Silver dwarfism, all of which were negative. At 9
months old, required nasogastric feeding for 6 months
following a history of failure to thrive. He has always been on
the lowest percentiles for stature. Growth hormone deficiency
was suggested indirectly via low levels of IGF1 and IGFBP3.
An MRI scan was reported as normal. His parents noted poor
vision and nyctalopia during his first year of life. There was
no family history of eye disease. One younger sibling who has
no visual problems was unavailable for further investigation.
Ophthalmic examination when he was six years old
disclosed a small angle alternating esotropia with mild
torsional nystagmus. Visual acuities were 0.4 and 0.5
logMAR in his right and left eyes, respectively. Cycloplegic
retinoscopy revealed a refractive error of 0.00 diopter sphere/
+3.00 diopter cylinder at 180 degrees in the right eye, and
+3.00 diopter sphere /+2.50 diopter cylinder at 180 degrees in
the left. He had normal color vision, according to Hardy Rand
Rittler; he had normal pupil reactions and clear lenses.
Funduscopy revealed a hyperpigmented area of retina
surrounding the optic disc with a fine granular pigmentation
of the RPE throughout the fundus (Figure 2). There was no
vascular attenuation.
ERGs were performed according to international
standards [13]. The dark-adapted bright flash ERG was
markedly electronegative with additional a-wave reduction.
Light-adapted flicker ERGs were delayed and subnormal and
the single flash cone ERG was subnormal with a reduced b:a
ratio (Figure 3). The profoundly negative ERG suggests
dysfunction that is both marked and at a level that is post-
phototransduction, usually post-receptoral. The a-wave was
subnormal but not delayed, indicating additional loss of
photoreceptor function. The ON-OFF and S-cone ERGs [17,
18] suggesting greater ON- than OFF- bipolar pathway
involvement. The pattern ERG P50 component was reduced
bilaterally, which is consistent with macular involvement.
(Figure 3)
DISCUSSION
This study provides evidence of a novel mutation in OTX2
associated with early onset retinal dystrophy and pituitary
insufficiency. This mutation is predicted to lead a truncated
protein. Chatelain et al. [19] observed that OTX2 truncation
at residues 106 and 161, flanking the site of the predicted
termination, described here, leads to loss of transactivation
function. This strongly suggests that the mutation identified
in our patient is also likely to cause haploinsufficiency.
Clinical studies have demonstrated that mutations in
OTX2 are associated with a wide range of ocular phenotypes
(Table 1) [7,11,20–22]. Experimentally, the role of OTX2 in
regional specification of the eye, particularly the RPE, has
long been established from expression studies in normal and
mutant animal models [1,4,23–26]. Subsequent studies have
also demonstrated the role of OTX2 in the development of both
the retinal photoreceptors and bipolar cells [25,27]. It has been
hypothesized that OTX2 is involved in retinal photoreceptor
cell fate but not in bipolar cell fate in early development, while
it is involved in the terminal differentiation of both
Figure 2. Fundus photography. Images are right and left eye color fundus photograph composites of patient NH13424 performed using
TOPCON retinal camera at 2.45x magnification at 35 degrees. Composite images were created using Adobe Photoshop. Image cropping and
reflections are observed secondary to poor pupil dilatation. The images show significant and abnormal peripapillary hyperpigmentation with
fine granular pigmentation at the level of the retinal pigment epithelium (RPE).
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photoreceptors and bipolar cells late in development in
cooperation with CRX [8]. Pituitary dysfunction has been
described in two patients with heterozygous 14q22–23
microdeletions involving OTX2 [28,29]. Recently, the role of
OTX2 in pituitary development has been further delineated
with three case reports of OTX2 mutations associated with
pituitary hormone deficiency (CPHD) [21,22]. A further case
of anophthalmia associated with an OTX2 mutation was
reported to have isolated growth hormone deficiency and
short stature [7]. In the latter publication a requirement for
OTX2 binding was postulated at a site previously shown to
lie in the promoter of HESX1 [30].
Figure 3. Electrophysiology. Full-field
ERGs and pattern ERGs from the right
(row 1) and left eye (row 2) of the patient
and normal examples (row 3) for
comparison. Full-field ERGs were
performed using corneal electrodes in
August 2007; pattern ERGs had been
recorded to a 30 degree field
checkerboard stimulus using periorbital
surface electrodes two years earlier.
Dark-adapted ERGs are shown for flash
intensities of 0.01 and 11.5 cd.s.m−2;
light-adapted ERGs for a flash intensity
of 3.0 cd.s.m−2 at 30 Hz (flicker) and at
2 Hz.. ON-OFF ERGs used an orange
stimulus (560 cd.m−2, duration 200 ms)
superimposed on a green background
(150 cd.m−2). S-cone ERGs used a blue
stimulus (445 nm, 80 cd.m−2) on an
orange background (620 nm, 560 cd.m
−2). Eye movement artifacts are replaced
by broken lines for clarity. S-cone ERGs
were unavailable for the right eye.
TABLE 1. PREVIOUSLY PUBLISHED MUTATIONS IN OTX2 WITH ASSOCIATED PHENOTYPES.
Nucleotide Protein Phenotype Reference
c.674A>G p.Asn225Ser CPHD [22]
c.674A>G p.Asn225Ser CPHD [22]
whole gene deletion whole gene deletion Extreme microphthalmia [20]
whole gene deletion whole gene deletion Anophthalmia [20]
c.93C>G p.Tyr31X Microphthalmia [20]
c.106dupC p.Arg36ProfsX52 Microphthalmia OD/ normal OS [20]
c.106dupC p.Arg36ProfsX52 Anophthalmia OD/ Coloboma OS [20]
c.289C>T p.Gln97X Extreme microphthalmia [20]
c.289C>T p.Gln97X Inferior iris coloboma OD/ retinal coloboma OS [20]
c.373_374delAG p.Gly126TrpfsX11 Anophthalmia [20]
c.404_405dupCT p.Ser136LeufsX43 Anophthalmia and CPHD [21]
c.402dupC p.Ser135LeufsX2 Anophthalmia, GH deficiency; cleft palate [7]
c.463_464dupGC p.Ser156LeufsX23 bilateral anophthalmia; developmental delay [11]
c.265C>G p.Arg89Gly bilateral microphthalmia [11]
c.81delC p.Ser28ProfsX23 bilateral severe microphthalmia [11]
c.537T>A p.Tyr179X severe microphthalmia and colobomata, developmental delay seizures [11]
c.537T>A p.Tyr179X bilateral mild microphthalmia, retinal dystrophy originally described as LCA [11]
c.117_118delCC p.Arg40GlyfsX47 bilateral anophthalmia [11]
c.295C>T p.Gln99X bilateral anopthalmia [11]
c.397C>A p.Pro133Thr bilateral microphthalmia [11]
c.400C>G p.Pro134Ala anophthalmia OS/ OD normal [11]
Mutations in OTX2. a summary of the published cases. Table lists previously published mutations in OTX2 with associated
phenotypes. The nucleotide and protein nomenclature used conforms to current standards and may differ from the notation used
in the original publications (LOVD). Abbreviations: CPHD represents combined pituitary hormone deficiency; OD represents
right eye; OS represents left eye; GH represents growth hormone.
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The phenotypic spectrum described in this case report is
consistent with the assigned multiple roles of OTX2 in the
development and function of both RPE and neural retinal, as
well as in the pituitary. Mutations in OTX2 are a rare cause of
infantile onset retinal dystrophies and the finding of an
electronegative ERG with additional a-wave reduction
suggests that there is dysfunction at the level of the
photoreceptor and also post-phototransduction, likely to
involve both ON- and OFF- bipolar cells. Funduscopy
revealed a fine granular pigmentation of the RPE. In addition,
an unusual hyperpigmented juxtapapillary ring, not normally
seen in retinal dystrophies, was observed. The history of early
failure to thrive and subsequent short stature with low implied
growth hormone levels adds further support for a role for
OTX2 in pituitary function.
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